nach oben

Erschienen in:

01.05.2010 | Original Article

Gastric Hyposecretion in Esophageal Squamous-Cell Carcinomas

verfasst von: K. Iijima, T. Koike, Y. Abe, H. Yamagishi, N. Ara, K. Asanuma, K. Uno, A. Imatani, N. Nakaya, S. Ohara, T. Shimosegawa

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Recently, gastric fundic atrophy is reported to be an independent risk factor for esophageal squamous-cell carcinoma (ESCC). The aim of this study is to investigate the acid secretory level in ESCC in a case-control study. From April 2004 to March 2008, 100 consecutive subjects with early ESCC and 100 age- and sex-matched asymptomatic controls were prospectively enrolled. Gastrin-stimulated acid output was assessed by endoscopic gastrin test. Conditional regression analyses were used to adjust for other potential confounders. Multivariate analyses revealed a strong association between profound hypochlorhydria and ESCC with odds ratio (95% confidence interval): 6.0 (1.9–18.4). The association remained significant after adjusting for the effect of gastric atrophy as a covariate. The association became stronger as the ESCC developed more distal site of the esophagus. This study indicates that profound hypochlorhydria is a strong independent risk factor for ESCC even after adjusting for the influence of gastric atrophy.

Lambert R, Hainaut P. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:921–945. doi:10.1016/j.bpg.2007.10.001.CrossRefPubMed

Center for cancer control and information services, national cancer center, Japan. http://ganjoho.ncc.go.jp/pro/statistics/en/graph_db_index.html; 2009.

Kuwano H, Morita M, Tsutsui S, Kido Y, Mori M, Sugimachi K. Comparison of characteristics of esophageal squamous cell carcinoma associated with head and neck cancer and those with gastric cancer. J Surg Oncol. 1991;46:107–109. doi:10.1002/jso.2930460208.CrossRefPubMed

Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–439.PubMed

Kokawa A, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Nakanishi Y. Other primary cancers occurring after treatment of superficial oesophageal cancer. Br J Surg. 2001;88:439–443. doi:10.1046/j.1365-2168.2001.01696.x.CrossRefPubMed

Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11–15. doi:10.1136/gut.33.1.11.CrossRefPubMed

Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388–396.PubMedCrossRef

Ye W, Nyren O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalized for pernicious anaemia. Gut. 2003;52:938–941. doi:10.1136/gut.52.7.938.CrossRefPubMed

Iijima K, Koike T, Abe Y, et al. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous-cell carcinoma in Japan. Am J Gastroenterol. 2007;102:1603–1609. doi:10.1111/j.1572-0241.2007.01257.x.CrossRefPubMed

10.

Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–3560.PubMed

11.

Rohrer GV, Welsh JD. Correlative study: gastric secretion and histology. Gastroenterology. 1967;52:185–191.PubMed

12.

El-Omar EM, Oien K, El-Nujumi A, et al. l. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997;113:15–24. doi:10.1016/S0016-5085(97)70075-1.CrossRefPubMed

13.

Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol. 1997;32:664–668. doi:10.3109/00365529708996515.CrossRefPubMed

14.

Takeshita K, Tani M, Inoue H, et al. Endoscopic treatment of early esophageal or gastric cancer. Gut. 1997;40:123–127.PubMed

15.

Makuuchi H. Endoscopic mucosal resection for early esophageal cancer: indication and techniques. Dig Endosc. 1996;8:175–179.

16.

Inoue H, Tani M, Nagai K, et al. Treatment of esophageal and gastric tumors. Endoscopy. 1993;31:47–55. doi:10.1055/s-1999-13647.CrossRef

17.

Muir CS, Mckinney PA. Cancer of the esophagus: a global overview. Eur J Cancer Prev. 1992;1:259–264. doi:10.1097/00008469-199204000-00007.CrossRefPubMed

18.

Goldstein HM, Zornoza J. Association of squamous cell carcinoma of the head and neck with cancer of the esophagus. AJR Am J Roentgenol. 1978;131:791–794.PubMed

19.

Misiewicz JJ, Tytgat GN, Goodwin CS. The Sydney system; a new classification of gastritis. Working party reports; 1990: 1–10.

20.

Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9:245–253. doi:10.1007/s10120-006-0397-0.CrossRefPubMed

21.

Yanaoka K, Oka M, Mukoubayashi C, et al. Cancer high-risk subjects by serum pepsinogen tests: outcomes after 10-years follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev. 2008;17:838–845. doi:10.1158/1055-9965.EPI-07-2762.CrossRefPubMed

22.

Iijima K, Ohara S, Sekine H, et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol. 1998;93:2113–2118. doi:10.1111/j.1572-0241.1998.00603.x.CrossRefPubMed

23.

Iijima K, Ohara S, Sekine H, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut. 2000;46:20–26. doi:10.1136/gut.46.1.20.CrossRefPubMed

24.

Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–334. doi:10.1136/gut.49.3.330.CrossRefPubMed

25.

Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther. 2004;19:1181–1188. doi:10.1111/j.1365-2036.2004.01948.x.CrossRefPubMed

26.

Gao YT, McLaughlin JK, Blot WJ, et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. J Cancer. 1994;58:192–196.

27.

Takezaki T, Shinoda M, Hatooka S, et al. Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan). Cancer Causes Control. 2000;11:597–608. doi:10.1023/A:1008909129756.CrossRefPubMed

28.

International Agency for Research on Cancer. Alcohol drinking. IARC Monogr. 1988;44:186–194.

29.

International Agency for Research on Cancer. Tobacco smoking. IARC Monogr. 1986;38:270–275.

30.

Segawa K, Nakazawa S, Tsukamoto Y, et al. Chronic alcohol abuse leads to gastric atrophy and decreased gastric secretory capacity: a histological and physiological study. Am J Gastroenterol. 1988;83:373–379.PubMed

31.

Whitfield PF, Hobsley M. Comparison of maximal gastric secretion in smokers and non-smokers with and without duodenal ulcer. Gut. 1987;28:557–560. doi:10.1136/gut.28.5.557.CrossRefPubMed

32.

Iijima K, Ohara S, Koike T, Sekine H, Shimosegawa T. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol. 2004;39:709–716. doi:10.1080/00365520410005911.CrossRefPubMed

33.

Haruma K, Komoto K, Kawaguchi H, et al. Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am J Gastroenterol. 1995;90:1107–1110.PubMed

34.

El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphism associated with increased risk of gastric cancer. Nature. 2000;404:398–402. (correction published in Nature 2001;412:99).CrossRefPubMed

35.

Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8–251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330–335. doi:10.1136/gut.2003.033050.CrossRefPubMed

36.

Svendsen JH, Svendsen CD, Christiansen PM. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand J Gastroenterol. 1986;21:16–20. doi:10.3109/00365528609034615.CrossRefPubMed

37.

Mowat C, William C, Gillen D, et al. Omeprazole, Helicobacter pylori status and alteration in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000;119:339–347. doi:10.1053/gast.2000.9367.CrossRefPubMed

38.

Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;29:17–48. doi:10.1016/0304-3835(95)03786-V.CrossRef

39.

Väkeväinen S, Mentula S, Nuutinen H, et al. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol. 2002;37:648–655. doi:10.1080/00365520212500.CrossRefPubMed

40.

Väkeväinen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Färkkilä M. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol. Aliment Pharmacol Ther. 2000;14:1511–1518. doi:10.1046/j.1365-2036.2000.00858.x.CrossRefPubMed

41.

Vaca CE, Nilsson JA, Fang JL, Grafström RC. Formation of DNA adducts in human buccal epithelial cells exposed to acetaldehyde and methylglyoxal in vivo. Chem Biol Interact. 1998;108:197–208. doi:10.1016/S0009-2797(97)00107-5.CrossRefPubMed

42.

Murphy SJ, Anderson LA, Johnston BT, et al. Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study. World J Gastroenterol. 2005;11:7290–7295.PubMed

43.

McColl KE. Helicobacter pylori and oesophageal cancer–not always protective. Gut. 2007;56:457–459. doi:10.1136/gut.2006.111385.CrossRefPubMed

44.

Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastoenterology. 1963;45:14–26.

45.

Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastro-esophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006;101:926–933. doi:10.1111/j.1572-0241.2006.00497.x.CrossRefPubMed

46.

Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s esophagus in Japan. Am J Gastroenterol. 2004;99:1213–1221. doi:10.1111/j.1572-0241.2004.30313.x.CrossRefPubMed

Titel: Gastric Hyposecretion in Esophageal Squamous-Cell Carcinomas
verfasst von: K. Iijima
T. Koike
Y. Abe
H. Yamagishi
N. Ara
K. Asanuma
K. Uno
A. Imatani
N. Nakaya
S. Ohara
T. Shimosegawa
Publikationsdatum: 01.05.2010
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 5/2010
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-009-0853-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2010

Plant-Derived Polysaccharide Supplements Inhibit Dextran Sulfate Sodium-Induced Colitis in the Rat

Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract in South China: A Retrospective Study of 561 Cases

Precut Papillotomy: A Risky Technique Not Only for Experts but Also for Average Endoscopists Skilled in ERCP

Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients

Patient Self-Administered Abdominal Pressure to Reduce Loop Formation During Minimally Sedated Colonoscopy